Jane Wasman, President, International and GC at ACORDA THERAPEUTICS INC (ACOR), sold 3,750 shares at $35.74 ($134K) on 2013-10-03, disclosed to the SEC on 2013-10-07.
Scheduled sale ($134k) by President, International and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $126K | — | Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |